216 related articles for article (PubMed ID: 23101488)
21. Time-course of health status in patients with rheumatoid arthritis during the first year of treatment with infliximab.
Ban A; Inaba M; Furumitsu Y; Okamoto K; Yukioka K; Goto H; Nishizawa Y
Biomed Pharmacother; 2010 Feb; 64(2):107-12. PubMed ID: 19944558
[TBL] [Abstract][Full Text] [Related]
22. Which factors influence radiographic progression during treatment with tumor necrosis factor inhibitors in clinical practice? Results from 930 patients with rheumatoid arthritis in the nationwide Danish DANBIO registry.
Ørnbjerg LM; Østergaard M; Bøyesen P; Krogh NS; Thormann A; Tarp U; Poulsen UE; Espesen J; Schlemmer A; Graudal N; Kollerup G; Jensen DV; Madsen OR; Glintborg B; Christensen T; Lindegaard H; Bøhme W; Hansen A; Andersen AR; Hetland ML
J Rheumatol; 2014 Dec; 41(12):2352-60. PubMed ID: 25274894
[TBL] [Abstract][Full Text] [Related]
23. Soluble macrophage-derived CD163 is a marker of disease activity and progression in early rheumatoid arthritis.
Greisen SR; Moller HJ; Stengaard-Pedersen K; Hetland ML; Hørslev-Petersen K; Jørgensen A; Hvid M; Deleuran B
Clin Exp Rheumatol; 2011; 29(4):689-92. PubMed ID: 21813065
[TBL] [Abstract][Full Text] [Related]
24. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan.
Matsui T; Kuga Y; Kaneko A; Nishino J; Eto Y; Chiba N; Yasuda M; Saisho K; Shimada K; Tohma S
Ann Rheum Dis; 2007 Sep; 66(9):1221-6. PubMed ID: 17369281
[TBL] [Abstract][Full Text] [Related]
25. The efficacy and safety of leflunomide in patients with active rheumatoid arthritis.
Wiacek R; Kolossa K; Jankowski T; Jeka S; Karmowski A; Karmowski M; Gworys B
Adv Clin Exp Med; 2012; 21(3):337-42. PubMed ID: 23214197
[TBL] [Abstract][Full Text] [Related]
26. Persistent periodontal disease hampers anti-tumor necrosis factor treatment response in rheumatoid arthritis.
Savioli C; Ribeiro AC; Fabri GM; Calich AL; Carvalho J; Silva CA; Viana VS; Bonfá E; Siqueira JT
J Clin Rheumatol; 2012 Jun; 18(4):180-4. PubMed ID: 22647860
[TBL] [Abstract][Full Text] [Related]
27. The Reliability of Disease Activity Score in 28 Joints-C-Reactive Protein Might Be Overestimated in a Subgroup of Rheumatoid Arthritis Patients, When the Score Is Solely Based on Subjective Parameters: A Cross-sectional, Exploratory Study.
Jensen Hansen IM; Asmussen Andreasen R; van Bui Hansen MN; Emamifar A
J Clin Rheumatol; 2017 Mar; 23(2):102-106. PubMed ID: 27870649
[TBL] [Abstract][Full Text] [Related]
28. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
Combe B; Rincheval N; Benessiano J; Berenbaum F; Cantagrel A; Daurès JP; Dougados M; Fardellone P; Fautrel B; Flipo RM; Goupille P; Guillemin F; Le Loët X; Logeart I; Mariette X; Meyer O; Ravaud P; Saraux A; Schaeverbeke T; Sibilia J
J Rheumatol; 2013 Oct; 40(10):1650-7. PubMed ID: 23950185
[TBL] [Abstract][Full Text] [Related]
29. Biomarkers in Remission According to Different Criteria in Patients with Rheumatoid Arthritis.
Yilmaz-Oner S; Ozen G; Can M; Atagunduz P; Direskeneli H; Inanc N
J Rheumatol; 2015 Nov; 42(11):2066-70. PubMed ID: 26472417
[TBL] [Abstract][Full Text] [Related]
30. [Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL)].
Karateev DE; Luchikhina EL; Tiurina LN; Chemeris NA; Pogozheva EIu; Lukina GV; Potanin AIu; Shostak NA; Kogan KM; Demidova NV; Kasumova KA; Pozdniakova ES; Fedorenko EV; Aleksandrova EN; Novikov AA; Smirnov AV; Nasonov EL
Ter Arkh; 2008; 80(5):8-13. PubMed ID: 18590106
[TBL] [Abstract][Full Text] [Related]
31. Five-year survival on infliximab in rheumatoid arthritis patients: analysis from an Italian registry (GISEA) by different calendar years.
Iannone F; Salaffi F; Marchesoni A; Gorla R; Atzeni F; Govoni M; Gremese E; Lapadula G; On Behalf Of Gisea Gruppo Italiano di Studio Sulle Early Arthritides A
Clin Exp Rheumatol; 2015; 33(4):524-30. PubMed ID: 26087761
[TBL] [Abstract][Full Text] [Related]
32. Persistently active disease is common in patients with rheumatoid arthritis, particularly in women: a long-term inception cohort study.
Svensson B; Andersson M; Forslind K; Ajeganova S; Hafström I;
Scand J Rheumatol; 2016 Nov; 45(6):448-455. PubMed ID: 27095008
[TBL] [Abstract][Full Text] [Related]
33. Disease factors in early rheumatoid arthritis are associated with differential risks for cardiovascular events and mortality depending on age at onset: a 10-year observational cohort study.
Ajeganova S; Andersson ML; Frostegård J; Hafström I
J Rheumatol; 2013 Dec; 40(12):1958-66. PubMed ID: 23950188
[TBL] [Abstract][Full Text] [Related]
34. Body mass index and response to abatacept in rheumatoid arthritis.
Gardette A; Ottaviani S; Sellam J; Berenbaum F; Lioté F; Fautrel B; Palazzo E; Meyer A; Sibilia J; Dieudé P
Eur J Clin Invest; 2016 Dec; 46(12):1048-1052. PubMed ID: 27736006
[TBL] [Abstract][Full Text] [Related]
35. Number of active joints, not diagnosis, is the primary determinant of function and performance in early synovitis.
Gerber LH; Furst G; Yarboro C; el-Gabalawy H
Clin Exp Rheumatol; 2003; 21(5 Suppl 31):S65-70. PubMed ID: 14969053
[TBL] [Abstract][Full Text] [Related]
36. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.
Furst DE; Kavanaugh A; Florentinus S; Kupper H; Karunaratne M; Birbara CA
Rheumatology (Oxford); 2015 Dec; 54(12):2188-97. PubMed ID: 26199453
[TBL] [Abstract][Full Text] [Related]
37. Very recent onset arthritis--clinical, laboratory, and radiological findings during the first year of disease.
Machold KP; Stamm TA; Eberl GJ; Nell VK; Dunky A; Uffmann M; Smolen JS
J Rheumatol; 2002 Nov; 29(11):2278-87. PubMed ID: 12415582
[TBL] [Abstract][Full Text] [Related]
38. Changes and sex differences in patient reported outcomes in rheumatoid factor positive RA-results from a community based study.
Hekmat K; Jacobsson LT; Nilsson JÅ; Lindroth Y; Turesson C
BMC Musculoskelet Disord; 2014 Feb; 15():44. PubMed ID: 24552546
[TBL] [Abstract][Full Text] [Related]
39. Dietary Intake of Polyunsaturated Fatty Acids and Pain in Spite of Inflammatory Control Among Methotrexate-Treated Early Rheumatoid Arthritis Patients.
Lourdudoss C; Di Giuseppe D; Wolk A; Westerlind H; Klareskog L; Alfredsson L; van Vollenhoven RF; Lampa J
Arthritis Care Res (Hoboken); 2018 Feb; 70(2):205-212. PubMed ID: 28371257
[TBL] [Abstract][Full Text] [Related]
40. Relative efficiencies of the 7 rheumatoid arthritis Core Data Set measures to distinguish active from control treatments in 9 comparisons from clinical trials of 5 agents.
Pincus T; Richardson B; Strand V; Bergman MJ
Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-47-54. PubMed ID: 25365089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
